5:23 PM
 | 
May 20, 2013
 |  BC Extra  |  Top Story

Royalty ups bid as Elan unveils deals

Royalty Pharma (New York, N.Y.) raised its offer to acquire Elan Corp. plc (NYSE:ELN) on Monday shortly after Elan announced a flurry of proposed moves, including two proposed acquisitions, a spinout, a share buyback and an $800 million note deal. Royalty increased its bid to $12.50...

Read the full 220 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >